Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome.

Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome.

J Hum Virol. 1997 Nov-Dec;1(1):19-29. Unique Identifier : AIDSLINE MED/99211131
Kellam P; Boshoff C; Whitby D; Matthews S; Weiss RA; Talbot SJ; Institute of Cancer Research, Chester Beatty Laboratories,; London, United Kingdom.

Abstract: OBJECTIVES: Human herpesvirus 8 (HHV-8) is strongly associated with all forms of Kaposi's sarcoma (KS) and with primary effusion lymphomas (PEL). KS patients' sera are immunoreactive against discrete nuclear localizing antigens in PEL cell lines. This study sought to identify and characterize these nuclear localizing proteins. STUDY DESIGN/METHODS: KS patients' sera were used to screen a cDNA expression library derived from a PEL cell line (BCP-1) latently infected with HHV-8. RESULTS: An HHV-8-specific cDNA clone was isolated. It encoded one partial and two complete open reading frames (ORFs): ORF 73, ORF 72 (v-cyclin), and K13, respectively. The immunodominant epitope was mapped to the C-terminal domain of ORF 73. Analysis with the KS patients' sera of HEK 293 cells transfected with a clone encompassing the complete coding region of ORF 73, ORF 72, and K13 gave a nuclear immunofluorescence pattern similar to that observed in BCP-1 cells. Western blot analysis with KS patients' sera of transfected HEK 293 cells revealed an immunoreactive protein of 220 to 230 kD that was similar to that observed previously in PEL cell lines. After induction of lytic replication of HHV-8 in BCP-1 cells with n-butyrate, we observed a major reduction in the expression of an ORF 73-specific 6.6-kb mRNA, indicating that this region is under latent control. CONCLUSIONS: These data identify a region of HHV-8 encoding for a major immunoreactive latent nuclear antigen (LNA-1), analogous to the Epstein-Barr virus latent nuclear antigens.

Keywords: JOURNAL ARTICLE Amino Acid Sequence Antigens, Viral/*GENETICS/IMMUNOLOGY/METABOLISM Blotting, Western Cell Nucleus/*VIROLOGY Cells, Cultured Fluorescent Antibody Technique Genome, Viral Herpesvirus, Kaposi Sarcoma-Associated/*GENETICS/IMMUNOLOGY/ METABOLISM Human Immunodominant Epitopes/IMMUNOLOGY Molecular Sequence Data Nuclear Proteins/*GENETICS/IMMUNOLOGY Open Reading Frames/IMMUNOLOGY RNA, Messenger/GENETICS Sarcoma, Kaposi/IMMUNOLOGY/*VIROLOGY Sequence Homology, Amino Acid Support, Non-U.S. Gov't Transfection
990730
A9971151

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .